Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFβ/ALK5 signaling

Molecular Cell

Volumn 12, Issue 4, 2003, Pages 817-828

  Goumans, Marie José ^a,d   Valdimarsdottir, Gudrun ^a   Itoh, Susumu ^a   Lebrin, Franck ^a   Larsson, Jonas ^b   Mummery, Christine ^c   Karlsson, Stefan ^b   Ten Dijke, Peter ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c HUBRECHT INSTITUTE   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN RECEPTOR 1; ACTIVIN RECEPTOR LIKE KINASE 1; PROTEIN KINASE; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOLOGY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; MEDIATOR; NONHUMAN; PROTEIN DEFICIENCY; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0242330126     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(03)00386-1     Document Type: Article

References (34)

1. Attisano L., Carcamo J., Ventura F., Weis F.M., Massagué J., Wrana J.L. Identification of human activin and TGFβ type I receptors that form heteromeric kinase complexes with type II receptors. Cell. 75:1993;671-680.
2. Brummelkamp T.R., Bernards R., Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science. 296:2002;550-553.
3. Candia A.F., Watabe T., Hawley S.H., Onichtchouk D., Zhang Y., Derynck R., Niehrs C., Cho K.W. Cellular interpretation of multiple TGFβ signals. intracellular antagonism between activin/BVg1 and BMP-2/4 signaling mediated by Smads Development. 124:1997;4467-4480.
4. Carcamo J., Weis F.M., Ventura F., Wieser R., Wrana J.L., Attisano L., Massagué J. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor β and activin. Mol. Cell. Biol. 14:1994;3810-3821.
5. Chen Y.G., Massagué J. Smad1 recognition and activation by the ALK1 group of transforming growth factor-β family receptors. J. Biol. Chem. 274:1999;3672-3677.
6. Dennler S., Itoh S., Vivien D., ten Dijke P., Huet S., Gauthier J.M. Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17:1998;3091-3100.
7. Ebner R., Chen R.H., Lawler S., Zioncheck T., Lee A., Lopez A.R., Derynck R. Cloning of a type I TGFβ receptor and its effect on TGFβ binding to the type II receptor. Science. 260:1993;1344-1348.
8. Goumans M.-J., Mummery C. Functional analysis of the TGFβ receptor/Smad pathway through gene ablation in mice. Int. J. Dev. Biol. 44:2000;253-265.
9. Goumans M.-J., Valdimarsdottir G., Itoh S., Rosendahl A., Sideras P., ten Dijke P. Balancing the activation state of the endothelium via two distinct TGF β type I receptors. EMBO J. 21:2002;1743-1753.
10. He T.C., Zhou S., da Costa L.T., Yu J., Kinzler K.W., Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA. 95:1998;2509-2514.
11. Hendrix M.J., Seftor R.E., Seftor E.A., Gruman L.M., Lee L.M., Nickoloff B.J., Miele L., Sheriff D.D., Schatteman G.C. Transendothelial function of human metastatic melanoma cells. role of the microenvironment in cell-fate determination Cancer Res. 62:2002;665-668.
12. Inman G.J., Nicolas F.J., Callahan J.F., Harling J.D., Gaster L.M., Reith A.D., Laping N.J., Hill C.S. SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 62:2002;65-74. a.
13. Iseki S., Osumi-Yamashita N., Miyazono K., Franzen P., Ichijo H., Ohtani H., Hayashi Y., Eto K. Localization of TGFβ type I and type II receptors in mouse development. Exp. Cell Res. 219:1995;339-347.
14. Itoh S., Thorikay M., Kowanetz M., Moustakas A., Itoh F., Heldin C.-H., ten Dijke P. Elucidation of Smad requirement in transforming growth factor β type I receptor-induced responses. J. Biol. Chem. 278:2003;3751-3761.
15. Jonk L.J., Itoh S., Heldin C.-H., ten Dijke P., Kruijer W. Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-β, activin, and bone morphogenetic protein-inducible enhancer. J. Biol. Chem. 273:1998;21145-21152.
16. Jonson T., Albrechtsson E., Axelson J., Heidenblad M., Gorunova L., Johansson B., Hoglund M. Altered expression of TGFβ receptors and mitogenic effects of TGFβ in pancreatic carcinomas. Int. J. Oncol. 19:2001;71-81.
17. Korchynskyi O., ten Dijke P. Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J. Biol. Chem. 277:2002;4883-4891.
18. Larsson J., Goumans M.-J., Sjostrand L.J., van Rooijen M.A., Ward D., Leveen P., Xu X., ten Dijke P., Mummery C.L., Karlsson S. Abnormal angiogenesis but intact hematopoietic potential in TGFβ type I receptor-deficient mice. EMBO J. 20:2001;1663-1673.
19. Luo K., Lodish H.F. Signaling by chimeric erythropoietin-TGFβ receptors. homodimerization of the cytoplasmic domain of the type I TGFβ receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction EMBO J. 15:1996;4485-4496.
20. Luo K., Lodish H.F. Positive and negative regulation of type II TGFβ receptor signal transduction by autophosphorylation on multiple serine residues. EMBO J. 16:1997;1970-1981.
21. Lux A., Attisano L., Marchuk D.A. Assignment of transforming growth factor β1 and β3 and a third new ligand to the type I receptor ALK-1. J. Biol. Chem. 274:1999;9984-9992.
22. Massagué J. TGFβ signal transduction. Annu. Rev. Biochem. 67:1998;753-791.
23. Miettinen P.J., Ebner R., Lopez A.R., Derynck R. TGFβ induced transdifferentiation of mammary epithelial cells to mesenchymal cells. involvement of type I receptors J. Cell Biol. 127:1994;2021-2036.
24. Nakao A., Imamura T., Souchelnytskyi S., Kawabata M., Ishisaki A., Oeda E., Tamaki K., Hanai J., Heldin C.-H., Miyazono K., ten Dijke P. TGFβ receptor-mediated signaling through Smad2, Smad3 and Smad4. EMBO J. 16:1997;5353-5362.
25. Oh S.P., Seki T., Goss K.A., Imamura T., Yi Y., Donahoe P.K., Li L., Miyazono K., ten Dijke P., Kim S., Li E. Activin receptor-like kinase 1 modulates transforming growth factor- β1 signaling in the regulation of angiogenesis. Proc. Natl. Acad. Sci. USA. 97:2000;2626-2631.
26. Pepper M.S. Transforming growth factor-β vasculogenesis, angiogenesis, and vessel wall integrity Cytokine Growth Factor Rev. 8:1997;21-43.
27. Roberts A.B., Sporn M.B. Physiological actions and clinical applications of transforming growth factor-β (TGFβ). Growth Factors. 8:1993;1-9.
28. Roelen B.A., van Rooijen M.A., Mummery C.L. Expression of ALK1, a type 1 serine/threonine kinase receptor, coincides with sites of vasculogenesis and angiogenesis in early mouse development. Dev. Dyn. 209:1997;418-430.
29. ten Dijke P., Yamashita H., Ichijo H., Franzén P., Laiho M., Miyazono K., Heldin C.-H. Characterization of type I receptors for transforming growth factor-β and activin. Science. 264:1994;101-104.
30. Ward S.M., Desgrosellier J.S., Zhuang X., Barnett J.V., Galper J.B. TGFβ signaling via differential activation of Activin receptor-like kinases 2 and 5 during cardiac development. J. Biol. Chem. 277:2002;50183-50189.
31. Weis-Garcia F., Massagué J. Complementation between kinase-defective and activation-defective TGFβ receptors reveals a novel form of receptor cooperativity essential for signaling. EMBO J. 15:1996;276-289.
32. Wieser R., Wrana J.L., Massagué J. GS domain mutations that constitutively activate TβR-I, the downstream signaling component in the TGFβ receptor complex. EMBO J. 14:1995;2199-2208.
33. Wrana J.L., Attisano L., Wieser R., Ventura F., Massagué J. Mechanism of activation of the TGFβ receptor. Nature. 370:1994;341-347.
34. Yamashita H., ten Dijke P., Franzén P., Miyazono K., Heldin C.-H. Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-β J. Biol. Chem. 269:1994;20172-20178.